Exporting Iranian pharmaceutical products to Russia’s market: Potentials and Barriers

Document Type : Original

Authors

Department of Tourism Strategy and Management, Literature and Philosophy Faculty, University of Tor Vergata, Rome, Italy.

Abstract

The pharmaceutical market is one of the most important and lucrative industries in the trade world. The expansion of non-oil exports and shifting away from the mono-product economy and its problems (high volatility in the oil market and, consequently, the country's revenue, as well as the issue of sanctions on Iran's oil sales by the West) have made it inevitable for Iran to expand its export of pharmaceutical products. Meanwhile, the Russian Federation, for historical reasons, has a high potential to become a destination for Iran's pharmaceutical products due to the geographical proximity of the two countries and the possibility of direct shipment of goods to Russia via the Caspian Sea. Russia is a large consuming market with the population of 145 million and high volume of pharmaceutical imports (over 10.5$ billion in 2018). The article analyses the pharmaceutical export potential of Iran to the Russian Federation using the indicators of revealed comparative advantage index, cosine index and trade plan index. The findings of this study indicate the high potential of Iranian pharmaceutical products for export to the Russian consuming market and the lack of utilization and the neglect of the Iranian pharmaceutical manufacturers and exporters from the Russian market. As policy implications, the authors recommend making pharmaceutical products a priority for export to the Russian market, which will lead to more efficient use of Iran's productive potential.

Keywords

Main Subjects

حوزة موضوعی: ایران و روسیه

Scope: Iran & Russia

References

Allen SRGD. (1957). Mathematical Economics. London: Macmillan & Co.
Barazesh A. (2014). Political-Diplomatic Relations between Iran and The World during the Safavid Era. Tehran: Amir Kabir Publications. [in Persian]
Bert T. (2008). “Parallel trade of pharmaceuticals: A review of legal, economic, and political aspects”. Value in Health. 11(5): 996–1005. doi: 10.1111/j.1524-4733.2008.00339.x.
Bojnec S, Ferto I. “Export competitiveness of dairy products on global markets: The case of the European Union countries”. Journal of Dairy Science. 97(10): 6151–6163. doi: 10.3168/jds.2013-7711.
Chadha A. (2009). “Product cycles, innovation, and exports: A study of Indian pharmaceuticals”. World Development. 37(9): 1478–1483. doi: 10.1016/j.worlddev.2009.01.002.
Chaudhry P, Dacin P. (1997). “Strategic planning in a regulated trade bloc: The pharmaceutical industry in the European Union”. European Management Journal. 15(6): 686–697. doi: 10.1016/S02632373(97)00052-2.
https://comtradeplus.un.org/  (Assessed on 14/05/2024)
Emamgholipour S, Aghel L. (2019). “Determining the structure of pharmaceutical industry in Iran”.  International Journal of Pharmaceutical and Healthcare Marketing. 13(1): 101–115. doi: https://doi.org/10.1108/IJPHM-06-2017-0030.
Garattini L, Padula A. (2018). “Competition in pharmaceuticals: more product– than price-oriented?”. The European Journal of Health Economics. 19: 1–4. doi: 10.1007/s10198-0170932-4.
Haghayegh R, Hassangholipoor T. (2017). “Iran-Russia commercial relations; A strategy for non-oil trading development”. International Relations Research. 1(27): 281-312.
Holownia-Voloskova M, Vorobiev PA, Grinin M, Davydovskaya M, Ermolaeva, T, Kokushkin K. (2018). “Drug policy in the Russian Federation”. Value in Health Regional Issues. 16: 106–111. doi: 10.1016/j.vhri.2018.09.001.
ICCIMA: Iran Chamber of Commerce, Industries, Mines and Agriculture (2017). https://iccima.ir/. (Assessed on 10/06/2017).
Karami J, Rasoulinezhad E, Shokri Sh. (2019). “Discussion on Russia-Iran bilateral trade in the modern era with emphasis on Russia’s economy”. Journal of World Sociopolitical Studies. 3(1): 161–198. doi: https://doi.org/10.22059/wsps.2019.272325.1079.
Koolaee E, Abedi A. (2018). “Developments of Iran-Russia relations, 1992–2016”. Studies of International Relations Journal. 10 (40): 135–164.
Mahmoudzadeh M, Karimi M, Hasanpour Y. (2011). "Analysis of Iran's competitiveness in the export of pharmaceutical products". Economic Policy Journal. 4(7): 55-78. [in Persian]
Miclitz W. (1988). “EC regulation of the export of dangerous pharmaceuticals to Third World countries: Some prospects”. Journal of Consumer Policy. 11: 29-53. doi: 10.1007/bf00411519.
Nasabian S, Gholamhosseini T, Jabal-Aamili F. (2011). "Comparison of the relative advantage of Iran's medicinal plant exports with other exporting countries (Case study: fennel, star anise, anise and coriander)". Economic Modeling. 6(4): 75-92. [in Persian]
The Observatory of Economic Complexity website. https://oec.world/en/. (Assessed on 10/07/2017).
Palumbo FB, Mullins CD, Slagle AF, Rizer J. (2007). “Policy implications of drug importation”. Clinical Therapeutics. 29(12): 2758–2767. doi: 10.1016/j.clinthera.2007.12.029.
Pourqasemi M. (2017). The Book of Export and Import Regulations of 2017. Tehran: Commercial Print and Publications Company. [in Persian]
Rahmani M, Abedin Moghanaki MR. (2008). "Examining the possibility of developing Iran's exports with selected commercial partners". Business Research Journal. 12(46): 145-177. [in Persian]
Rasoulinezhad E. (2016). “Investigation of sanctions and oil price effects on the Iran-Russia trade by using the gravity model”. Vestnik SPBGU. 5(2): 68–84. doi: 10.21638/11701/spbu05.2016.204.
Sajedi A, Sajedi S. (2019). “America's exit from joint comprehensive plan of action and turbulence in Iran's economy”. Studies of International Relations Journal. 12 (46): 123–155. doi: https://doi.org/DOR:20.1001.1.24234974.1398.12.46.4.7.
Settanni E, Seosamh Harrington T, Srai JS. (2017). “Pharmaceutical supply chain models: A synthesis from a systems view of operations research”. Operations Research Perspectives. 4: 74–95. doi: 10.1016/j.orp.2017.05.002.
Shahbazi K, Asadi F. (2013). "The effect of the increase in the exchange rate on the import of medicine and medical equipment”. Economic Policy Journal. 6(11): 35-54. [in Persian]
SPS Requirements for Exporting to the Russian Federation (2010), Translation of the Regulation APPROVED by the Decision of the Customs Union Commission. May 28, No 299.
Tannoury M, Attieh Z. (2017). “The influence of emerging markets on the pharmaceutical industry”. Current Therapeutic Research. 86: 19–22. doi: 10.1016/j.curtheres.2017.04.005.
http://ww25.tradmap.org/?subid1=20240706-1834-4400-a5b1-f7b45efb6d2a. (Assessed on 20/05/2024)
Valibeigi H, Fahimifar J, Abedinzadeh M. (2005). “Examining the export competitiveness of Iran's auto parts industry in export markets”. Journal of Commerce. 170-172. [in Persian]
Vassilieva Y. (2010). “Agricultural Ministry Sets Procedure for Examining Russian SPS Norms”. Global Agricultural Information Network. GAIN Report Number:RS1026.
Yu R, Cai J, Leung P. (2008). “The normalized revealed comparative advantage index”. The Annals of Regional Science. 43: 267–282. doi: 10.1007/s00168-008-0213-3.
Zargarzadeh A, Minaeiyan M, Torabi A. (2008). “Prescription and nonprescription drug use in Isfahan, Iran: An observational, cross-sectional study”. Current Therapeutic Research. 69(1): 76–87. doi: 10.1016/j.curtheres.2008.02.002.
Journal of Countries Studies
Volume 2, Issue 4
2024
Pages 599-623

Files

History

  • Receive Date: 26 May 2024
  • Revise Date: 30 June 2024
  • Accept Date: 06 July 2024

Share

How to cite

Statistics